您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 论文 • 上一篇    下一篇

影响T2期膀胱移行细胞癌患者预后因素分析

褚雷,李青,李博,赵庆利,李顺   

  1. 山东大学附属千佛山医院泌尿外科, 济南 250014
  • 收稿日期:2007-11-02 修回日期:1900-01-01 出版日期:2008-03-16 发布日期:2008-03-16
  • 通讯作者: 李青

Parameters influencing the longterm survival of patients with T2 stage transitional cell carcinoma of the bladder

CHU Lei, LI Qing, LI Bo, ZHAO Qingli, LI Shun   

  1. Department of Urology, Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, China
  • Received:2007-11-02 Revised:1900-01-01 Online:2008-03-16 Published:2008-03-16
  • Contact: LI Qing

摘要: 目的分析影响T2期膀胱移行细胞癌患者生存时间因素。方法1984~2004年间初次收治T2M0膀胱移行细胞癌患者共105例,获得随访85例,采用SPSS12.0软件对可能影响生存时间的因素(如病理特点、治疗方案等)进行Cox回归分析。结果病历资料3、5年疾病特异生存率分别为77.65%、65.88%。影响生存时间的因素分别为:区域淋巴结转移,危险比为4.809;病程2个月以上,危险比为3.035;肿瘤高分级,危险比为2.781,多发肿瘤,危险比为2.710;采用卡介苗(BCG)灌注较丝裂霉素C(MMC)灌注效果好,危险比为0.692。结论有无区域淋巴结转移对决定手术方式起重要作用;行保留膀胱手术患者可首先选择BCG灌注,不能耐受时可选用副作用较小的化疗药灌注;及时诊断治疗可改善患者预后及生存质量。

Abstract: To determine parameters affecting the longterm survival of patients with T2 stage transitional cell carcinoma of the bladder. MethodsFrom 1984 to 2004, 105 patients with T2M0 transitional cell carcinoma of bladder were treated, of which 85 patients were followed up. The possible survivalrelated factors including clinical and pathological figures were analyzed by Cox′s proportional hazard model in these patients. Results The 3-year and 5-year disease specific survival rates were 77.65% and 65.88%. Parameters affecting the longterm survival were: regional lymph nodes metastasis(the hazard ratio was 4.809), course over 2 month (the hazard ratio was 3.035), grade(the hazard ratio was 2.781), multiple tumors(the hazard ratio was 2.710), and the intravesical instillation of Bacille CalmetteGuérin was superior to the instillation of mitomycin C(the hazard ratio was 0.692). ConclusionsRegional lymph nodes metastasis plays an important role in the decision of the therapeutic regimen. BCG instillation is a good choice for patients who can not endure their side effects and choose the instillation of drugs such as mitomycin C. Survival time and life quality can be improved by prompt diagnosis and treatment.

Key words: Bladder neoplasms, Carcinoma, Transitional cell, Administration, Intravesical, Prognosis

中图分类号: 

  • R737.14
[1] 梁璐,梁凯,蒋玲,张晓黎. 两例家族性Gitelman综合征患者基因型和表型特点[J]. 山东大学学报(医学版), 2016, 54(12): 86-89.
[2] 刘益民,杜鲁涛,王丽丽,蒋秀梅,李娟,曲爱林,王海燕,郑桂喜,张欣,杨咏梅,王传新. 膀胱癌患者血清microRNA检测中内参基因的筛选及验证[J]. 山东大学学报(医学版), 2014, 52(5): 86-91.
[3] 倪永梁,李青. 树突状细胞治疗联合膀胱灌注表柔比星在TURBT术后的应用研究[J]. 山东大学学报(医学版), 2011, 49(2): 114-118.
[4] 高漓1,张天禹1,谭宁2,张琳刚1. 非CO2依赖型细胞培养系统对膀胱癌T-24细胞增殖的影响[J]. 山东大学学报(医学版), 2010, 48(10): 60-64.
[5] . TLR4在膀胱尿路上皮癌中的表达及意义[J]. 山东大学学报(医学版), 2009, 47(10): 80-82.
[6] 赵作辉1,2 ,孙波2 ,王建军2 ,姜亭起2 ,王万利2 ,李顺来2 , 董港2 ,
孙光1 ,畅继武1 ,马天加3
. 膀胱移行细胞癌中Survivin表达的意义 [J]. 山东大学学报(医学版), 2009, 47(03): 77-80.
[7] 张开舒,徐忠华,姜虹,阎磊,周尊林,王荣,刘海南,范医东,刘照旭,郑宝钟,亓天伟 . siRNA沉默膀胱癌肝素酶基因对T24细胞增殖及MMP-2表达的影响[J]. 山东大学学报(医学版), 2008, 46(6): 561-565.
[8] 郝钢跃,张月英,张维东,杨明山,贾青 . XRCC3基因多态性与汉族人群膀胱癌的相关性[J]. 山东大学学报(医学版), 2008, 46(6): 612-615.
[9] 马 鸣,李秀真,王 超,郭洪敏,马 鑫,张 旭 . MAGE-3抗原肽致敏DC疫苗抗膀胱癌细胞的体外实验[J]. 山东大学学报(医学版), 2008, 46(5): 485-489.
[10] 张怀强,周春文,马天加,王绍勇,葛南. 不同剂量卡介苗膀胱灌注预防浅表性膀胱癌复发的效果[J]. 山东大学学报(医学版), 2008, 46(5): 513-515.
[11] 卜洁琼,于保法 . 瘤内缓释治疗对B16黑色素瘤小鼠影响的实验研究[J]. 山东大学学报(医学版), 2007, 45(10): 988-991.
[12] 马云波,丁森泰,吕家驹. 吡喃阿霉素联合卡介苗灌注预防膀胱肿瘤复发的效果观察及尿中IL-8变化的研究[J]. 山东大学学报(医学版), 2007, 45(2): 171-174.
[13] . 靶向沉默Notch1基因对膀胱癌细胞系T24增殖的影响[J]. 山东大学学报(医学版), 2009, 47(9): 53-57.
[14] 倪永梁, 焦守镔, 朱国栋, 张华勤. 膀胱无功能性副节瘤1例并文献复习[J]. 山东大学学报(医学版), 2015, 53(1): 93-96.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!